Samsung Biologics
End-to-end biologics development and manufacturing at scale
Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Biologics / bioreactor infrastructure
- Bioreactor type
- Single-Use / DisposableStainless Steel
- Max bioreactor scale
- Large commercial (≤10,000 L)
Fill-finish formats
Regulatory clearances
Services
- Cell-Line Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- CMC Regulatory Submission Support
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Vial Filling
- Stability Testing & Storage
- Formulation Development
- Vaccine Manufacturing
- ADC Payload & Linker Synthesis
- Lipid Nanoparticle (LNP) Formulation
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
Indications
About this organization
Overview
Samsung Biologics is a leading contract development and manufacturing organization (CDMO) delivering high-quality end-to-end biologics with precision and at scale. The company offers seamless development and manufacturing services driven by continuous innovation and operational excellence.
Service Offerings
Research & Development
- Cell line development
- Process development and analytical development
- Formulation development
- CMC services and phase-appropriate technology platforms
- Organoid services
Manufacturing
- Drug Substance: Large-scale (5–15 kL) and small-scale (≤2 kL) clinical and commercial manufacturing
- Drug Product: Aseptic filling in liquid and lyophilized formats for vials, syringes, and cartridges
- Advanced Modalities: ADC development and manufacturing (payload & mAb preparation, conjugation, formulated bulk); mRNA DS and DP manufacturing (pDNA, IVT, LNP process development and manufacturing)
Quality Services
- Mycoplasma testing
- In vitro virus testing
- MVM qPCR testing
- Microbiology testing (microbial challenge, antimicrobial effectiveness, endotoxin, sterility, bioburden)
- Contract QC testing for batch release
Capabilities
The organization provides fully integrated, world-class CGMP facilities with seamless scale-up and commercial success focus. Services span from early development de-risking through clinical and commercial manufacturing with reliable global supply chains.
Locations
Bio Campus I
South Korea
Bio Campus II
South Korea
Headquarters / Bio Campus I
Incheon · Yeonsu-gu · Republic of Korea
Bio Campus II
Incheon · Yeonsu-gu · Republic of Korea
ADC Plant
Incheon · Yeonsu-gu · Republic of Korea
Samsung Biologics America
United States
Samsung Biologics Japan Office
Japan
Headquarters
Recent news about Samsung Biologics
Related companies
Similar profiles by shared services, modalities, and capabilities.
AGC Biologics- Cell-Line Development
- Process Development
Pfizer CentreOne- Process Development
- CMC Analytical Development
WuXi Biologics- Cell-Line Development
- Process Development
Celonic- Cell-Line Development
- Process Development
Wheeler Bio- Cell-Line Development
- Process Development
National Resilience- Process Development
- CMC Analytical Development
Simtra BioPharma Solutions- CMC Analytical Development
- Technology Transfer
FUJIFILM Biotechnologies- Cell-Line Development
- Process Development
Submit a verified review for this organization.
Markdown mirror: /companies/samsungbiologics.md